Treatment Options for Inflammation and Pain in Interstitial Cystitis

First-Line Treatment: Behavioral and Self-Care Approaches

A multimodal approach combining behavioral modifications, oral medications, and intravesical treatments should be implemented for managing inflammation and pain in interstitial cystitis/bladder pain syndrome (IC/BPS), with treatment selection based on symptom severity and patient characteristics 1, 2
Self-care practices and behavioral modifications should be discussed with all patients as initial management strategies 1, 2
Altering urine concentration through fluid management can help manage symptoms in patients with IC/BPS 1, 3
Application of local heat or cold over the bladder or perineum can help manage pain in patients with IC/BPS 3, 4
Avoidance of known bladder irritants, such as coffee, citrus products, and spicy foods, can help reduce symptoms in patients with IC/BPS 1, 2
Implementation of an elimination diet can help identify personal trigger foods in patients with IC/BPS 1, 3
Stress management techniques, such as meditation and imagery, can help manage symptoms in patients with IC/BPS 1, 2
Pelvic floor muscle relaxation, rather than strengthening exercises, can help manage symptoms in patients with IC/BPS 1, 4
Bladder training with urge suppression can help manage symptoms in patients with IC/BPS 1, 3
Over-the-counter products, such as quercetin and calcium glycerophosphates, may provide relief for patients with IC/BPS 1, 2, 3, 4

The American Urological Association recommends amitriptyline as a treatment option for IC/BPS, with a typical dosage of 10-100 mg per day 1, 2
Amitriptyline has been shown to be superior to placebo for symptom improvement in patients with IC/BPS, with an evidence strength of Grade B 1, 2
Common side effects of amitriptyline include sedation, drowsiness, and nausea 1, 2
Pentosan polysulfate is the only FDA-approved oral medication for IC/BPS, with a typical dosage of 100 mg three times daily 1

Heparin can help repair the damaged glycosaminoglycan (GAG) layer in patients with IC/BPS, with intravesical administration providing clinically significant improvement in symptoms 3, 4
Lidocaine can provide temporary relief of bladder pain in patients with IC/BPS, with intravesical administration providing rapid onset of action 3, 4

Multimodal pain management approaches should be initiated and maintained throughout treatment for patients with IC/BPS, with non-opioid alternatives preferred due to the chronic nature of the condition 1, 2, 3, 4
Pain management alone does not constitute sufficient treatment; underlying bladder symptoms must also be addressed in patients with IC/BPS 3, 4

Fulguration and/or injection of triamcinolone can provide significant relief for patients with Hunner's lesions, a specific subtype of IC/BPS 3, 5

Avoid strengthening exercises for pelvic floor muscles, as these may worsen symptoms in patients with IC/BPS 1, 2
Patients using pentosan polysulfate require regular ophthalmologic examinations due to risk of macular damage 1
IC/BPS is a chronic condition with periods of flares and remissions; patients should be educated about the long-term nature of management 1, 2
Treatment efficacy for any individual is unpredictable; multiple therapeutic options may need to be tried before adequate symptom control is achieved 1, 2

Over-the-counter products like quercetin and calcium glycerophosphates may provide relief, and cimetidine and hydroxyzine are additional second-line oral medication options, according to The American Urological Association 6
Dimethyl sulfoxide (DMSO) can be administered as 50 mL instillation directly into the bladder for 15 minutes, repeated every two weeks until maximum relief is obtained, as recommended by The American Urological Association 6

Cystoscopy should be performed in patients for whom Hunner lesions are suspected, as suggested by The American Urological Association 7
If Hunner's lesions are present, fulguration (with laser or electrocautery) and/or injection of triamcinolone should be performed, according to The American Urological Association 6
Hunner lesions can be easier to identify after distention when cracking and mucosal bleeding become evident, as noted by The American Urological Association 6

Sacral neuromodulation may be considered if other treatments have not provided adequate symptom control, as recommended by The American Urological Association 6
Cyclosporine A may be administered as an oral medication for refractory cases, according to The American Urological Association 6
Intradetrusor botulinum toxin A injections may be beneficial, but patients must be willing to accept the possibility of needing intermittent self-catheterization, as suggested by The American Urological Association 6
Multimodal pain management approaches should be initiated and maintained throughout treatment, as recommended by The American Urological Association 6
Pain management alone does not constitute sufficient treatment; underlying bladder symptoms must also be addressed, according to The American Urological Association 6
If pain management is inadequate, consider referral to pain specialists, as suggested by The American Urological Association 7

Document baseline symptoms using validated tools such as the genitourinary pain index (GUPI) or interstitial cystitis symptom index (ICSI) to measure treatment effects, as recommended by The American Urological Association 7